These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19102090)

  • 1. [Undesirable effects of methothrexate during treatment of rheumatoid arthritis].
    Ndongo S; Ka MM; Pouye A; Ka EF; Diallo S; Diop TM
    Dakar Med; 2007; 52(1):37-40. PubMed ID: 19102090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic maintenance level of methotrexate in rheumatoid arthritis].
    Tahiri L; Allali F; Jroundi I; Abouqal R; Hajjaj-Hassouni N
    Sante; 2006; 16(3):167-72. PubMed ID: 17284392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
    Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R
    J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of low dose methotrexate therapy in rheumatoid arthritis: a comparison of three different dosage regimens].
    Totokawa S; Furuya T; Nakajima A; Suzuki T; Kashiwazaki S
    Ryumachi; 1997 Oct; 37(5):681-7. PubMed ID: 9396370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between elevated mean red cell volume and haematological toxicity in patients receiving long-term methotrexate for rheumatoid arthritis.
    White DH; Chapman PT; O'Donnell JL; James J; Frampton C; Stamp LK
    Intern Med J; 2010 Aug; 40(8):561-5. PubMed ID: 19811562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.
    Lim AY; Gaffney K; Scott DG
    Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil].
    Sergiets NA; Erov NK
    Ter Arkh; 2009; 81(6):34-7. PubMed ID: 19663190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
    Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H
    Arthritis Rheum; 2009 Jul; 61(7):979-87. PubMed ID: 19565542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of rheumatoid arthritis associated with autoimmune hemolytic anemia due to weekly low-dose methotrexate therapy].
    Yoshida K; Kurosaka D; Ozawa Y; Yokoyama T; Tajima N
    Ryumachi; 2000 Aug; 40(4):693-8. PubMed ID: 11021173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Juvenile idiopathic arthritis treated by methotrexate: result of treatment and tolerance].
    Hajri R; Nasraoui R; Laatar A; Chekili S; Kassab S; Zakraoui L
    Tunis Med; 2005 Mar; 83(3):137-42. PubMed ID: 15929440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate and oral ulceration.
    Deeming GM; Collingwood J; Pemberton MN
    Br Dent J; 2005 Jan; 198(2):83-5. PubMed ID: 15702101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-related minor adverse effects in rheumatoid arthritis: more than a nuisance.
    Dhir V; Aggarwal A
    J Clin Rheumatol; 2012 Jan; 18(1):44-6. PubMed ID: 22157277
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methotrexate therapy of rheumatoid arthritis. An open observation study of 110 patients with median length of treatment of 17.8 month].
    Elling P
    Ugeskr Laeger; 1993 Jul; 155(30):2323-7. PubMed ID: 8346572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Appearance of impotence in relation to the use of methotrexate].
    Riba N; Moreno F; Costa J; Olive A
    Med Clin (Barc); 1996 Apr; 106(14):558. PubMed ID: 8656751
    [No Abstract]   [Full Text] [Related]  

  • 18. Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
    Vakily M; Amer F; Kukulka MJ; Andhivarothai N
    J Clin Pharmacol; 2005 Oct; 45(10):1179-86. PubMed ID: 16172183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Agarwal S; Zaman T; Handa R
    Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
    Yokoo H; Nakazato Y; Harigaya Y; Sasaki N; Igeta Y; Itoh H
    Acta Neuropathol; 2007 Oct; 114(4):425-30. PubMed ID: 17357801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.